Ingrid Delaet
Chief Regulatory Officer at Neurocrine Biosciences Inc (NBIX)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $3.7M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Jul 13SEC | NBIXNeurocrine Biosciences Inc | Sell Plan | 4,36716,225 held (−21%) | $181.02 | $791K | -21.3% |
| Jul 9SEC | NBIXNeurocrine Biosciences Inc | Sell Plan | 3,40116,225 held (−17%) | $178.57 | $607K | -20.2% |
| Jul 9SEC | NBIXNeurocrine Biosciences Inc | Sell Plan | 2,73716,225 held (−14%) | $178.54 | $489K | -20.2% |
| Jul 9SEC | NBIXNeurocrine Biosciences Inc | Sell Plan | 8,43316,225 held (−34%) | $178.72 | $1.5M | -20.3% |
| Jun 2SEC | NBIXNeurocrine Biosciences Inc | Sell Plan | 2,26116,225 held (−12%) | $156.71 | $354K | -9.1% |
- Sell
Chief Regulatory Officer Ingrid Delaet sold $791K of NBIX at $181.02 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Regulatory Officer Ingrid Delaet sold $607K of NBIX at $178.57 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Regulatory Officer Ingrid Delaet sold $489K of NBIX at $178.54 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Regulatory Officer Ingrid Delaet sold $1.5M of NBIX at $178.72 — cuts the stake by 34%; pre-scheduled 10b5-1 plan sale.
- Sell
Chief Regulatory Officer Ingrid Delaet sold $354K of NBIX at $156.71 — pre-scheduled 10b5-1 plan sale.